Cited by 179Immune Response and InflammationAlcohol Consumption and Health EffectsGut microbiota and health

Gut-Liver Axis and Sensing Microbes

Open access
Szabo, Gyongyi, Bala, Shashi, Petrasek, Jan, Gattu, Arijeet·2010·Digestive Diseases

Abstract

‘Detoxification’ of gut-derived toxins and microbial products from gut-derived microbes is a major role of the liver. While the full repertoire of gut-derived microbial products that reach the liver in health and disease is yet to be explored, the levels of bacterial lipopolysaccharide (LPS), a component of Gram-negative bacteria, is increased in the portal and/or systemic circulation in several types of chronic liver diseases. Increased gut permeability and LPS play a role in alcoholic liver disease where alcohol impairs the gut epithelial integrity through alterations in tight junction proteins. In addition, non-alcoholic fatty liver disease is also associated with increased serum LPS levels and activation of the pro-inflammatory cascade plays a central role in disease progression. Microbial danger signals are recognized by pattern recognition receptors such as the Toll-like receptor 4 (TLR4). Increasing evidence suggests that TLR4-mediated signaling via the MyD88-dependent or MyD88-independent pathways may play different roles in liver diseases associated with increased LPS exposure of the liver as a result of gut permeability. For example, we showed that in alcoholic liver disease, the MyD88-independent, IRF3-dependent TLR4 cascade plays a role in steatosis and inflammation. Our recent data demonstrate that chronic alcohol exposure in the liver leads to sensitization of Kupffer cells to LPS via a mechanism involving upregulation of microRNA-155 in Kupffer cells. Thus, understanding the cell-specific recognition and intracellular signaling events in sensing gut-derived microbes will help to achieve an optimal balance in the gut-liver axis and ameliorate liver diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000324281

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among the potential contributors of the microbiota to complications of liver cirrhosis is the presence of SIBO, and a dysfunctional mucosal barrier which can contribute to bacterial (or endotoxin) translocation to the portal circulation.

    “Among the potential contributors of the microbiota to complications of liver cirrhosis is the presence of SIBO [73] , and a dysfunctional mucosal barrier which can contribute to bacterial (or endotoxin) translocation to the portal circulation [74] .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [6]Szabo G. LPS in Liver Disease. Falk Meeting. 2008 [Google Scholar]

Cited by

Sorted by citations

Authors
Szabo, G., Bala, S., Petrasek, J., & Gattu, A.
Affiliations
University of Massachusetts Chan Medical School (US)
Venue
Digestive Diseases
Publisher
S. Karger AG
Published
2010
Volume
28
Issue
6
Pages
737-744
ISSN
  • 0257-2753 (ISSN-L)
  • 1421-9875
OpenAlex
W2067615993
Cited by
179
References
46
Citations by year
2026: 7 · 2025: 8 · 2024: 12 · 2023: 3 · 2022: 5 · 2021: 14 · 2020: 12 · 2019: 8 · 2018: 20 · 2017: 15 · 2016: 19 · 2015: 15 · 2014: 14 · 2013: 15 · 2012: 12
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • Digestive Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism (R01AA017729, AA017729, #AA011576, R01AA011576)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
gut-liver axis, lipopolysaccharide, bacterial endotoxemia, intestinal permeability, alcoholic liver disease, non-alcoholic fatty liver disease, TLR4, MyD88-independent signaling, IRF3, Kupffer cells, miR-155, steatosis, liver inflammation, pattern recognition receptors, tight junctions
MeSH terms
Animals, Disease, Homeostasis, Humans, Liver, Permeability, Gastrointestinal Tract, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review